Repackaging (revision 6)
Old revision·11:04, 15 Nov 2024·FreightFenna
| Repackaging | |
|---|---|
| Operation | Transfer to a new container, or relabelling |
| Risk | Severed traceability |
| Mitigation | New record referencing the original lot |
| Topic infobox · conventions | |
Repackaging is the transfer of material from one container into another, or the relabelling of an existing container under a new identifier. It is a legitimate and common operation, and it is also the point at which lot traceability is most often lost.[1]
A repackager who assigns a new batch number without recording the original one has severed the link between the container and every determination ever made on the material. The resulting vial cannot be associated with any certificate, however genuine that certificate is.[2]
Repackaging also introduces its own risks. Material is exposed to the environment during transfer, containers and closures may differ from those the stability data were generated in, and any new dating is a fresh assertion rather than an inherited one.[3]
Why the record is the whole thing
[edit]Nothing about repackaged material is detectable by analysis. A repackaged peptide is the same molecule, and a determination on it returns the same numbers; what has changed is what is known about where it came from.[2]
| Practice | Effect on traceability |
|---|---|
| New identifier referencing the original lot | Preserved |
| New identifier, original recorded internally | Preserved if records are retrievable |
| New identifier, original not recorded | Severed |
| Original identifier retained | Preserved, but may misattribute the repackaging step |
The last row is subtler than it looks. Retaining the original identifier preserves the link to the manufacturer's records but conceals that a repackaging step occurred, so the container's history is understated rather than lost.
This is why the observable indicators described at Lot traceability — identifier agreement across vial, certificate and paperwork, and retrievability of a certificate for an older lot — are the practical tests available to a purchaser.[4]
References
- ^ International Council for Harmonisation, Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (2000).
- ^ a b ISO 9001:2015, Quality management systems — Requirements, clause 8.5.2.
- ^ United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.
- ^ PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see Project:Sourcing guidelines).